SynthesisPLoS biology2017

Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review.

James Mattina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.